Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, is pleased to announce with immediate effect the acquisition of the assets of an established biomaterial and ...
ReN001, which is derived from a neural stem cell line, is in a Phase I stroke trial. Angel Biotechnology signed a contract with ReNeuron to perform development and GMP manufacturing services to ...
SAN CLEMENTE, Calif., March 13, 2025 /PRNewswire/ -- Angelalign Technology Inc. (HK:6699) (Angel Aligner™) www.angelaligner.com a global leader in orthodontic clear aligner technology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results